• Something wrong with this record ?

Two panels of steroid receptor luciferase reporter cell lines for compound profiling

D. Sedlák, A. Paguio, P. Bartůněk,

. 2011 ; 14 (4) : 248-66.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS). The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors. In the first panel, the activation of either synthetic, steroid response elements containing promoter or viral promoter is mediated by full-length steroid receptors. The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the molecule by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter. Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode. We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qualitative response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels. However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts. Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compound libraries (HTS) and for detailed study of mechanisms by which compounds exert their biological effects.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027762
003      
CZ-PrNML
005      
20130118102720.0
007      
ta
008      
120817s2011 ne f 000 0#eng||
009      
AR
024    7_
$a 10.2174/138620711795222446 $2 doi
035    __
$a (PubMed)21375502
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Sedlák, David $u Center for Chemical Genetics, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Vídeňská, Prague, Czech Republic. bartunek@img.cas.cz
245    10
$a Two panels of steroid receptor luciferase reporter cell lines for compound profiling / $c D. Sedlák, A. Paguio, P. Bartůněk,
520    9_
$a Steroid hormone receptors represent a major target in drug discovery. As ligand inducible transcription factors, their activity can be modulated by small lipophilic molecules. Here we describe two panels of potent and selective luciferase reporter cell lines based on cells with low endogenous steroid receptor activity (U2OS). The panels contain reporter cell lines for estrogen receptors α and β, androgen, glucocorticoid, mineralocorticoid, and progesterone receptors. In the first panel, the activation of either synthetic, steroid response elements containing promoter or viral promoter is mediated by full-length steroid receptors. The second panel is based on the expression of the chimeric receptor, which was created by the replacement of the N-terminal part of the molecule by Gal4 DBD and that binds to multiple UAS sites in the reporter promoter. Both panels were extensively characterized by profiling 28 ligands in dose response manner in agonist and antagonist mode. We have analyzed and compared the responses to tested ligands from both panels and concluded that in general both systems generated similar qualitative response in terms of potency, efficacy, partial agonism/antagonism, mixed agonistic/antagonistic profiles and the rank of potencies was well conserved between both panels. However, we have also identified some artifacts introduced by the Gal4/LBD reporter assays in contrast to their full-length receptor reporter counterparts. Keeping in mind the advantages and drawbacks of each reporter format, these cell lines represent powerful and selective tools for profiling large compound libraries (HTS) and for detailed study of mechanisms by which compounds exert their biological effects.
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a objevování léků $x metody $7 D055808
650    _2
$a reportérové geny $7 D017930
650    _2
$a genetické inženýrství $x metody $7 D005818
650    _2
$a rychlé screeningové testy $x metody $7 D057166
650    _2
$a lidé $7 D006801
650    _2
$a luciferasy $x genetika $x metabolismus $7 D008156
650    _2
$a plazmidy $x genetika $7 D010957
650    _2
$a promotorové oblasti (genetika) $x účinky léků $7 D011401
650    _2
$a steroidní receptory $x agonisté $x antagonisté a inhibitory $x genetika $x metabolismus $7 D011987
650    _2
$a rekombinantní proteiny $x genetika $x metabolismus $7 D011994
650    _2
$a sekvenční delece $7 D017384
650    _2
$a knihovny malých molekul $x analýza $7 D054852
650    _2
$a steroidy $x farmakologie $7 D013256
650    _2
$a transkripční faktory $x genetika $x metabolismus $7 D014157
650    _2
$a aktivace transkripce $x účinky léků $7 D015533
650    _2
$a transfekce $7 D014162
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Paguio, Aileen
700    1_
$a Bartůněk, Petr
773    0_
$w MED00180203 $t Combinatorial chemistry & high throughput screening $x 1875-5402 $g Roč. 14, č. 4 (2011), s. 248-66
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21375502 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120817 $b ABA008
991    __
$a 20130118102834 $b ABA008
999    __
$a ok $b bmc $g 949804 $s 785108
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 14 $c 4 $d 248-66 $i 1875-5402 $m Combinatorial chemistry & high throughput screening $n Comb Chem High Throughput Screen $x MED00180203
LZP    __
$a Pubmed-20120817/11/03

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...